Neuroendocrine Tumors Treatment Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis

The Global Neuroendocrine Tumor Treatment Market was valued at US$ 1,197.3 million in 2016 and is projected to expand at a CAGR of 10.5% during the forecast period (2017-2025), as highlighted in a new report published by Coherent Market Insights. Better diagnostic techniques and products in pipeline are expected to be major factors driving growth of the global neuroendocrine tumor treatment market over the foreseeable future.
Neuroendocrine Tumor (NET) are diagnosed more frequently in the U.S. than other countries worldwide. According to U.S. Surveillance Epidemiology and End Results (SEER) Register, in 35 years prior to 2016, the number of GI neuroendocrine tumors/carcinomas of the small intestine has increased 300%-500%, which will drive an ample opportunity for the emerging pharma companies focusing on neuroendocrine tumor treatment drugs. Pulmonary neuroendocrine tumor treatment comprise around 25% of all kinds of neuroendocrine tumor treatment. According to Louisiana State University Health Sciences Center, 2016, Pulmonary Neuroendocrine Tumor Treatment have a low incidence in the U.S., with a rate of 1.6/100,000 individuals. Typical Carcinoid (TC) comprise 1-2% and Atypical Carcinoid (AC) comprise 0.1-0.2% of all pulmonary tumors, whereas small cell lung carcinoma (SCLC) and Large Cell Neuroendocrine Carcinoma (LCNECs) make up 20% and 1.6-3%, respectively
Overall survival is good for the well-differentiated Typical Carcinoid tumors is 92-100% and moderate for AC 61-88%, whereas the higher grade, poorly differentiated SCLC and LCNET have a grim prognosis with OS as low as 5%
According to stats released by the American Society of Clinical Oncology in 2014, an estimated 12,000 people are diagnosed with a neuroendocrine tumor and 1,500 people are diagnosed with Merkel cell skin cancer in the U.S. each year. Most of the patients were in the age group 60-65 years, with 90% are white people. This disease if undiagnosed within the first two years of its occurrence, reduces survival rate to around 60%. Survival rate of neuroendocrine cancer becomes much higher if it is detected in early stages, prior spreading to the lymph nodes or any distant parts of the human body. The GI neuroendocrine tumor is the one of the most common indication causing liver metastases, particularly when it effected in the midgut origin. Appendix is the second most common location for midgut carcinoids it acts as a carrier for the spread of the disease to entire liver.
Around 90 out of 100 people survive for 5 years or more if the carcinoid started in the appendix gastrointestinal neuroendocrine tumors is inherently a diverse group of cells or tumors that sometimes generate various peptides triggering characteristic hormonal disorders. Neuroendocrine tumor treatment can be categorized into clinically symptomatic (functioning) or silent (non-functioning). Both types of NET produce more than one peptide, though these are not associated with specific syndromes.
Key takeaways of the neuroendocrine tumor treatment market:
• The global neuroendocrine tumor treatment market is expected to expand at a CAGR of 10.5% during the forecast period (2017-2025) as there exists a huge unrealized market especially in Asia Pacific, Latin America, Middle East and Africa
• The Sunitinib Malate and Sufatinib dominates the market in the drug segment, as it is used to treat progressive, well-differentiated advanced and/or metastatic pancreatic neuroendocrine tumors and show a good tolerance in Grade 3 NET patients too.
• Gastrointestinal neuroendocrine tumor and pancreatic neuroendocrine tumor are the major indication segment of neuroendocrine tumor treatment market, as these indication are highly prevalent in regions like North America and Asia Pacific
• Some of the major players involved in global neuroendocrine tumor treatment market are Pfizer Inc, Novartis AG, Ispen, Advanced Accelerator Applications, Tarveda Therapeutics, Progenics Pharmaceuticals, Inc., Hutchison Medipharma Limited, Dauntless Pharmaceuticals Inc.and Exelixis, Inc.

Global Waste Treatment Disposal Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Published Date : Feb 2019

Waste Treatment Disposal market includes many types of waste, like waste water, solid waste, this report only focus on the solid waste that can be treatment though the methods of landfill, incineration, recycling etc. The solid waste includes Municipal Solid Waste (MSW), Commercial and Industrial (...

Global Hyperpigmentation Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Published Date : Feb 2019

Hyperpigmentation can be caused by sun damage, inflammation, or other skin injuries, including those related to acne vulgaris.People with darker skin tones are more prone to hyperpigmentation, especially with excess sun exposure.[4] Scope of the Report: The whole approaches are us...

Global Acinetobacter Infections Treatment Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Published Date : Feb 2019

Acinetobacter is a group of bacteria commonly found in soil and water. While there are many types or "species" of Acinetobacter and all can cause human disease, Acinetobacter baumannii accounts for about 80% of reported infections. Outbreaks of Acinetobacter infections typically occur i...

Global Laser Treatment Devices of Varicose Veins Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Published Date : Feb 2019

Laser Treatment Devices of Varicose Veins is an alternative to surgical stripping. It closes the vein permanently by delivering the laser energy inside the vein (rather than fishing the vein and tearing it away from its side branches like stripping does). Removing or closing the saphenous veins is n...

Global Swimming Pool Water Treatment Equipment Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Published Date : Feb 2019

Swimming pool water treatment equipment is used to treat the water from the swimming pool. Swimming pool water must undergo treatment, in order to remain clear and clean, free from harmful substances, bacteria, viruses, algae and other pathogens and suitable for use by swimmers. Swimming pool...

Global Nanoparticle Analysis Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Published Date : Feb 2019

Nanoparticle Analysis utilizes the properties of light scattering to detect the partical size distribution, zeta potential, molecular weight, etc. of samples, and can be used to analyze samples of nanoparticle, colloform, emulsion, submicron suspension, etc. The light scattered by the particles is c...

Global Thermal Treatment Air Filtration Systems Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Published Date : Feb 2019

Thermal treatment air filtration is a method of filtering exhaust gases generated by various industrial processes. The exhaust gases are heated to a very high temperature in the oxidizing chamber, thus breaking the bond between polluting compounds. The compounds then mix with the oxygen present in t...

Global Soil Treatment Market Research Report 2019

Published Date : Jan 2019

Soil Treatment Report by Material, Application, and Geography - Global Forecast to 2023 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany...

Global Water Treatment Equipment Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Published Date : Feb 2019

Water Treatment Equipment refers to the equipment used in the industrial water treatment. It includes: Pre-treatment non-membrane, Pre-treatment membrane, ultrapure water, AD/EDI systems polishing, Inorganic WW treatment, Organic WW treatment, etc. Scope of the Report: The Europe...

Global Chemotherapy Induced Peripheral Neuropathy Treatment Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Published Date : Jan 2019

CIPN is a common adverse effect of several cancer therapies including taxanes and platinum drugs. Symptoms include decreased sensation and tingling of the hands and feet, severe pain, numbness and muscle weakness, all of which can occur during cancer treatment, and frequently persist after chemother...

 

Select License :

  • Single User : $4500
  • Multiple User : $7000
  • Corporate User : $10000

Happy To Assist You

Assist you at Worldwide Market Reports

We will be happy to help you find what you need. Please call us or write to us:

Worldwide Market Reports Benefits

Custom Research Solution

Talk to our research consultant to design an exclusive report as per your research needs.

Customer Fulfilment

We aim to fulfil client's research demands with tailored research solutions.

Quick Turnaround Time Reports

We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

360-degree Approach

We cover each industry from supply and demand side with an aim to provide a most holistic research study.